Sciwind Biosciences Co., Ltd. ('Sciwind'), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's National ...

I was diagnosed with Type 1 diabetes at the age of nine and have tried a number of ways to keep my blood glucose levels under control ...

Katie Murray, a nutritionist at gut supplement brand AltruVita, concurred that intermittent fasting can assist certain individuals in stabilising their blood sugar by giving the body a break from ...

Having had diabetes for just shy of 20 years, I have learned which foods and drinks to avoid. But there's one habit I've been doing on and off for years that seems to keep my blood glucose levels in ...

The use of hybrid closed-loop systems in adults with T1D and comorbid depression and/or anxiety disorders appears to be safe and is linked to improved glycaemic outcomes, a real-world study finds.

HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Recently, the results of the pivotal Phase III clinical trial (EECOH-1) of ecnoglutide injection, developed by Sciwind Biosciences Co., Ltd. ("Sciwind"), ...

A major achievement in diabetes care is emerging from the All India Institute of Medical Sciences (AIIMS), where doctors say metabolic surgery can be a life changing solution for people with Type-2 ...

Surgery was superior to medical therapy for reducing HbA1c and weight loss, irrespective of Area Deprivation Index.

In this randomized controlled trial in Israel, researchers examined whether a contingent discount as a financial incentive on ...

Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...